Company Profile-Sunvou

Introduction of the Founder

Han Jie

Ph.D. in Chemical Engineering (China) and Materials Science (USA)

Founder, Chairman and General Manager of Sunvou (2008 - ) Talent introduced by the state in 2004 / Talent introduced by Wuxi in 2008 / Innovative Talent of the Ministry of Science and Technology in 2017

Over 100 Patents, Over 100 Papers, and 4 Monographs in Nanotechnology

Won more than 10 awards for innovation and entrepreneurship, including the Feynman Nanotechnology Award in 1997

Company Introduction

SUNVOU is global leader in breath molecular diagnosis technology innovations, with the most granted patents, the most registered products, 400+ peer reviewed publications, 5,000+ devices in hospitals and 15 million+ tests from 2012 to 2024, founded by formal NASA, Honeywell, CISCO and Huawei scientists & engineers, joined by MIT and UC Berkeley graduates.

Development History

2008-2010

• The Company was Established • Established Class II medical electronic equipment production line and supporting quality management system • Obtained Class II Medical Device Production License of the PRC • Conferred with "Rising Star" Honorary Title • Secured the first Medical Device Registration Certificate for its products

2011-2013

• Attained EU CE Certification • Acquired ISO 13485:2003 and ISO 9001:2008 Quality Management System Certification Certificates • Conferred with the "Future Star" Honorary Recognition • Granted the Title of "National High-Tech Enterprise" • Secured the Second Prize in the Startup Track of the 2nd China Innovation and Entrepreneurship Competition

2014-2016

• Obtained 3 new registration certificates for medical device products • Recognized as an Advanced Demonstration Unit for Standardized Management of Enterprise Intellectual Property in Jiangsu Province • Listed on the NEEQ, Stock Code: 835730

2017-2018

• Awarded the title of "Wuxi AAA-Level Enterprise Honoring Contracts and Keeping Promises" • Awarded the honorary title of "Gazelle Enterprise of Southern Jiangsu National Independent Innovation Demonstration Zone" • Sunvou's product portfolio has expanded to 4 major series, with a total of 21 registered products, entering over 1,000 hospitals across 30 provinces and municipalities nationwide

2019-2021

• 9 new registered products added, total reaching 38; maintains global No.1 in number of products in exhalation diagnosis field • Named "Wuxi Exhaled Molecular Diagnosis Engineering Technology Research Center" • Topping-out of Sunvou's new building • "Expert Consensus on Pediatric Exhaled Nitric Oxide Detection & Clinical Application (2021)" (based on Sunvou's tech) officially released in Chinese Journal of Practical Pediatrics • "Chinese Expert Consensus on Exhaled Nitric Oxide Detection Tech & Airway Disease Application" (based on Sunvou 's tech) officially released at "2021 Chronic Airway Disease Management Summit & 2nd China Airway Disease Congress"